LONETTI, ANNALISA
LONETTI, ANNALISA
DIBINEM - DIPARTIMENTO DI SCIENZE BIOMEDICHE E NEUROMOTORIE
Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitors
2022 Mancini M.; De Santis S.; Monaldi C.; Castagnetti F.; Lonetti A.; Bruno S.; Dan E.; Sinigaglia B.; Rosti G.; Cavo M.; Gugliotta G.; Soverini S.
Exploiting clonal evolution to improve the diagnosis and treatment efficacy prediction in pediatric aml
2021 Bertuccio S.N.; Anselmi L.; Masetti R.; Lonetti A.; Cerasi S.; Polidori S.; Serravalle S.; Pession A.
hGATA1 Under the Control of a μLCR/β-Globin Promoter Rescues the Erythroid but Not the Megakaryocytic Phenotype Induced by the Gata1 low Mutation in Mice
2021 Martelli, F.; Verachi, P.; Zingariello, M.; Mazzarini, M.; Vannucchi, A. M.; Lonetti, A.; Bacci, B.; Sarli, G.; Migliaccio, A. R.
B-all complexity: Is targeted therapy still a valuable approach for pediatric patients?
2020 Ratti S.; Lonetti A.; Follo M.Y.; Paganelli F.; Martelli A.M.; Chiarini F.; Evangelisti C.
Inhibition of methyltransferase dot1l sensitizes to sorafenib treatment aml cells irrespective of mll-rearrangements: A novel therapeutic strategy for pediatric aml
2020 Lonetti A.; Indio V.; Laginestra M.A.; Tarantino G.; Chiarini F.; Astolfi A.; Bertuccio S.N.; Martelli A.M.; Locatelli F.; Pession A.; Masetti R.
Insights on the Interplay between Cells Metabolism and Signaling: A Therapeutic Perspective in Pediatric Acute Leukemias
2020 Anselmi Laura; Bertuccio S.N.; Lonetti A.; Prete A.; Masetti R.; Pession A.
Uncommon cytogenetic abnormalities identifying high-risk acute myeloid leukemia in children
2020 Masetti R.; Bertuccio S.N.; Guidi V.; Cerasi S.; Lonetti A.; Pession A.
New advances in targeting aberrant signaling pathways in T-cell Acute Lymphoblastic Leukemia.
2019 F. Paganelli, A. Lonetti, L. Anselmi, A.M. Martelli, C. Evangelisti, F. Chiarini.
Successes and Challenges for Diagnosis and Therapy of Acute Leukemia
2019 Lonetti, Annalisa; Iacobucci, Ilaria; Masetti, Riccardo
Targeted Therapies for Pediatric AML: Gaps and Perspective
2019 Lonetti, Annalisa; Pession, Andrea; Masetti, Riccardo
Targeting Hedgehog pathway in pediatric acute myeloid leukemia: challenges and opportunities
2019 Pession, Andrea; Lonetti, Annalisa; Bertuccio, Salvatore; Locatelli, Franco; Masetti, Riccardo*
Nuclear translocation of PKC-alpha is associated with cell cycle arrest and erythroid differentiation in myelodysplastic syndromes (MDSs)
2018 Poli, Alessandro; Ratti, Stefano; Finelli, Carlo; Mongiorgi, Sara; Clissa, Cristina; Lonetti, Annalisa; Cappellini, Alessandra; Catozzi, Alessia; Barraco, Marilena; Suh, Pann-Ghill; Manzoli, Lucia; McCubrey, James A.; Cocco, Lucio*; Follo, Matilde Y.
Phosphatidylinositol 3-kinase inhibition potentiates glucocorticoid response in B-cell acute lymphoblastic leukemia
2018 Evangelisti, Cecilia; Cappellini, Alessandra; Oliveira, Mariana; Fragoso, Rita; Barata, João T.; Bertaina, Alice; Locatelli, Franco; Simioni, Carolina; Neri, Luca M.; Chiarini, Francesca; Lonetti, Annalisa; Buontempo, Francesca; Orsini, Ester; Pession, Andrea; Manzoli, Lucia; Martelli, Alberto Maria; Evangelisti, Camilla
Therapeutic targeting of CK2 in acute and chronic leukemias.
2018 F. Buontempo, E. Orsini, M. Ruzzene, J.A. McCubrey, F. Chiarini, A. Cappellini, A. Lonetti, C. Evangelisti, C. Evangelisti, J.T. Barata, A.M. Martelli.
Hh/Gli antagonist in acute myeloid leukemia with CBFA2T3-GLIS2 fusion gene
2017 Riccardo Masetti; Salvatore Nicola Bertuccio; Annalisa Astolfi; Francesca Chiarini; Annalisa Lonetti; Valentina Indio; Matilde De Luca; Jessica Bandini; Salvatore Serravalle; Monica Franzoni; Martina Pigazzi; Alberto Maria Martelli; Giuseppe Basso; Franco Locatelli; Andrea Pession
Identification of a cytogenetic and molecular subgroup of acute myeloid leukemias showing sensitivity to L-Asparaginase.
2017 Bertuccio, SALVATORE NICOLA; Serravalle, S; Astolfi, Annalisa; Lonetti, Annalisa; Indio, Valentina; Leszl, A; Pession, Andrea; Melchionda, Fraia
Advances in understanding the acute lymphoblastic leukemia bone marrow microenvironment: from biology to therapeutic targeting.
2016 Chiarini, F; Lonetti, A; Evangelisti, C; Buontempo, F; Orsini, E; Evangelisti, C; Cappellini, A; Neri, LM; McCubrey, Ja; Martelli, AM.
COMBINAZIONE DI EPZ-5676 E SORAFENIB COME NUOVA STRATEGIA TERAPEUTICA PER IL TRATTAMENTO DELLE LEUCEMIE ACUTE MIELOIDI PEDIATRICHE
2016 Lonetti, A.; Masetti, R.; Bertuccio, N.; Serravalle, S.; Astolfi, A.; Bertaina, A.; Locatelli, F.; Martelli, A.M.; Pession, A.
COMBINING DOT1L INHIBITOR EPZ-5676 WITH SORAFENIB TO TREAT MLL-REARRANGED (MLL-R) PEDIATRIC ACUTE MYELOID LEUKEAMIA (AML)
2016 Lonetti, A; Masetti, R; Bertuccio, Sn; Serravalle, S; Astolfi, A; Bertaina, A; Locatelli, F; Martelli, Am; Pession, A
DOT1L INHIBITOR EPZ-5676 SYNERGIZES WITH SORAFENIB IN PRECLINICAL MODELS OF PEDIATRIC ACUTE MYELOID LEUKEAMIA (AML)
2016 Lonetti, A.; Masetti, R.; Bertuccio, N.; Serravalle, S.; Astolfi, A.; Bertaina, A.; Locatelli, F.; Martelli, A.M.; Pession, A.;